Inference Clinical Research Services Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 53.56%
- Profit Growth 42.29%
- Ebitda 28.99%
- Net Worth 74.63%
- Total Assets -20.77%
About Inference Clinical Research Services
Inference Clinical Research Services Private Limited (ICRSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2018 (Six years and three months 12 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anindita Bhattacharjee and Kalyan Ghosh serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999PN2018PTC180171
- Company No.
180171
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2018
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Inference Clinical Research Services?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyan Ghosh  | Director | 14-Nov-2018 | Current |
Anindita Bhattacharjee  | Director | 14-Nov-2018 | Current |
Financial Performance of Inference Clinical Research Services.
Inference Clinical Research Services Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.56% increase. The company also saw a substantial improvement in profitability, with a 42.29% increase in profit. The company's net worth Soared by an impressive increase of 74.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inference Clinical Research Services?
Unlock access to Inference Clinical Research Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inference Clinical Research Services?
Inference Clinical Research Services has a workforce of 39 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inference Clinical Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inference Clinical Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.